DYN Return on Tangible Equity | Dyne Therapeutics, Inc.

Dyne Therapeutics, Inc. (DYN) Return on Tangible Equity

2026-06-30: Return Tang Equity -73.97%.
2026-03-31: Return Tang Equity -52.22%.
2025-12-31: Return Tang Equity -45.90%.
2025-09-30: Return Tang Equity -61.26%.

Complete source-backed return tang equity history.

Available history: 2019-12-31 to 2026-06-30
Data captured: 2026-09-04

Historical Return Tang Equity

Date	Return Tang Equity
2026-06-30	-73.97%
2026-03-31	-52.22%
2025-12-31	-45.90%
2025-09-30	-61.26%
2025-06-30	-72.25%
2025-03-31	-54.88%
2024-12-31	-50.40%
2024-09-30	-41.74%
2024-06-30	-33.23%
2024-03-31	-53.84%
2023-12-31	-258.44%
2023-09-30	-136.89%
2023-06-30	-91.50%
2023-03-31	-73.04%
2022-12-31	-66.61%
2022-09-30	-72.50%
2022-06-30	-63.49%
2022-03-31	-47.53%
2021-12-31	-40.55%
2021-09-30	-30.46%
2021-06-30	-21.54%
2021-03-31	-16.00%
2020-12-31	-17.36%
2020-09-30	-9.87%
2020-06-30	3914.05%
2020-03-31	-252.28%
2019-12-31	-105.86%

Annual Return Tang Equity

Date	Return Tang Equity
2025-12-31	-45.90%
2024-12-31	-50.40%
2023-12-31	-258.44%
2022-12-31	-66.61%
2021-12-31	-40.55%
2020-12-31	-17.36%
2019-12-31	-105.86%

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
Arcus Biosciences, Inc. (RCUS)	United States	$3.188B	-8.52
Arcutis Biotherapeutics, Inc. (ARQT)	United States	$3.303B	115.47
Enliven Therapeutics, Inc. (ELVN)	United States	$3.307B	-35.07
Amylyx Pharmaceuticals, Inc. (AMLX)	United States	$3.361B	-13.15
PRECIGEN, INC. (PGEN)	United States	$2.757B	-12.94
NewAmsterdam Pharma Co N.V. (NAMS)		$2.719B	-15.37
MBX Biosciences, Inc. (MBX)	United States	$2.664B	-25.36
IDEAYA Biosciences, Inc. (IDYA)	United States	$3.540B	-20.52
Organon & Co. (OGN)	United States	$3.603B	17.03
Disc Medicine, Inc. (IRON)	United States	$2.553B	-11.40